CDC – Childhood Immunization Schedule – Haemophilus influenzae type b conjugate vaccine
Haemophilus influenzae type b conjugate vaccine (Hib) – Minimum age: 6 weeks
• If PRP-OMP (PedvaxHIB® or ComVax® [Merck]) is administered at ages 2 and 4 months, a dose at age 6 months is not required.
• TriHIBit® (DTaP/Hib) combination products should not be used for primary immunization but can be used as boosters following any Hib vaccine in children age 12 months or older.
CPT: For conjugate vaccines report any one of the below given CPT’s based upon the dose schedule.
90645 Hemophilus influenza b vaccine (Hib), HbOC conjugate (4 dose schedule), for intramuscular use
90646 Hemophilus influenza b vaccine (Hib), PRP-D conjugate, for booster use only, intramuscular use
90647 Hemophilus influenza b vaccine (Hib), PRP-OMP conjugate (3 dose schedule), for intramuscular use
90648 Hemophilus influenza b vaccine (Hib), PRP-T conjugate (4 dose schedule), for intramuscular use
For TriHIBit® (DTaP/Hib) combination vaccines report CPT 90721 Diphtheria, tetanus toxoids, and acellular pertussis vaccine and Hemophilus influenza B vaccine (DtaP-Hib), for intramuscular use.
Report any of the above applicable vaccine codes with the administration code CPT 90465 or CPT 90466 (if the vaccine is administered in addition to anyother vaccine).
ICD: V03.81 Need for prophylactic vaccination against hemophilus influenza type B (Hib)
Glossary: Conjugate vaccine is a type of vaccine that is created by joining bacterial polysaccharide antigen to a protein molecule. Conjugated vaccines are usually used to immunize babies and children against certain bacterial infections.